Johns Hopkins

A Bigger Role for Pharmacists
A Bigger Role for PharmacistsFrom bioterror attacks to the opioid epidemic, pharmacists are in a great place to help.
Walgreens Launches Site for its Outcomes Research Studies
Walgreens Launches Site for its Outcomes Research StudiesNew Walgreens website will showcase the chain’s research on adherence and other topics.
How to Cope with Residency StressResidency programs are teaching young pharmacists how to cope with stress.
Four priorities your health plan must embrace to thrive in the future
Four priorities your health plan must embrace to thrive in the futureHealth plans of the future will focus on consumers: designing products, care and services to support improved health.
Clinical team alignment top priority for payersInvestment in resources that support clinicians and patients closer to the point of care may be the cure for what ails managed care executives.
Value-based care takes over J.P. Morgan Healthcare Conference 2017Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.
New cancer care approach: Highmark’s cancer collaborativeCancer care has made great strides in the U.S., but effective care is still too expensive and inaccessible for many Americans. Now, payers and providers at Highmark, Allegheny Health Network and Johns Hopkins are launching a new model that could change cancer collaboration.
Glaucoma procedures decreasing among Medicare beneficiaries
Glaucoma procedures decreasing among Medicare beneficiariesDespite an increase in Medicare beneficiaries since 1994, the number of glaucoma-related surgeries has decreased, according to a recent study published in Ophthalmology.
More than 40% of physicians not using Rx monitoring sitesMost primary care physicians are aware of prescription drug monitoring programs (PMPs) designed to prevent doctor shopping, but more than four out of 10 are not using them, according to a survey published in the March issue of Health Affairs.
Lower-intensity statins plus bile acid sequestrant considered good option for some heart patients, study findsCombination therapy with a lower-intensity statin and bile acid sequestrant or ezetimibe lowered LDL cholesterol similar to or better than higher-intensity statin monotherapy among patients with high risk for atherosclerotic cardiovascular disease (ASCVD), according to a study published February 11 online in the Annals of Internal Medicine.